Table 1 Number of patients in the cohort with cohort with each malignancy type and chemotherapy regimen used

 Breast

4

 Non-small-cell lung cancer

4

 Pancreatic

2

 Bladder

1

 Cholangiocarcinoma

1

 Endometrial

1

 Osteosarcoma

1

 Mesothelioma

1

 Small-cell lung cancer

1

 Urothelial

1

 Unknown primary

1

 Platinum agent + Gemcitabine

6

 Doxorubicin + Cyclophosphamide + Paclitaxel

4

 Platinum agent + Etoposide

2

 Cisplatin + Doxorubicin

1

 Capecitabine

1

 Carboplatin + Paclitaxel

1

 Cisplatin + Pemetrexed

1

 Oxaliplatin + Irinotecan +5FU

1

 Abraxane

1